Works matching IS 21641153 AND DT 2022 AND VI 12 AND IP 3

Results: 14

Peptide-Based CoVac-1 Vaccine Shows Promise Against COVID-19 in Patients with Cancer.

Published in:: Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 3, p. 166
Publication type:: Article

First-Line Sotorasib Shows Long-Lasting Responses in Metastatic NSCLC with KRAS Mutation.

Published in:: Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 3, p. 165
Publication type:: Article

Genetic Score Makes PSA Screening More Accurate.

Published in:: Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 3, p. 164
Publication type:: Article

New Standards of Care for Melanoma.

Published in:: Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 3, p. 162
Publication type:: Article

NCCN Guidelines Update: Initial Colorectal Screening Lowered to Age 45.

Published in:: Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 3, p. 161
Publication type:: Article

New Oncology Drugs and New Indications Approved by the FDA.

Published in:: Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 3, p. 158
Publication type:: Article

Managing Resistant Fusarium Infections in Immunocompromised Pediatric Patients with Malignancy: 2 Case Reports and Review of the Literature.

Published in:

Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 3, p. 151

By:

Elder, Joshua J.;
Harwood, Kyle A.;
Gulley, Savannah L.;
Infanti, Lisa M.;
Holt, Mason T.

Publication type:

Article

Vancomycin Infusion Reaction: A Clinical and Therapeutic Overview.

Published in:

Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 3, p. 146

By:

Haque, Sakib;
Cubbison, Conner;
Pucik, Kendal;
Bubalo, Joseph

Publication type:

Article

Reduced Starting Dose of Tyrosine Kinase Inhibitors in Patients with Metastatic Renal-Cell Carcinoma.

Published in:

Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 3, p. 138

By:

Stitt, Tia M.;
Saunders, Katherine M.;
Rowling, Brooke C.;
Waller, Jennifer L.;
Clemmons, Amber B.

Publication type:

Article

Evaluation of Clinical Pharmacy Services for Phase 1 Clinical Trials.

Published in:

Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 3, p. 131

By:

Saunders, Jacqueline;
Murli, Sumati;
Rudek, Michelle A.;
Khandoobhai, Anand;
DeLisa, Anne;
Goodrich, Amy;
Mighty, Janet

Publication type:

Article

Pharmacist-Driven Intervention Significantly Increases Biosimilar Adoption in Clinical Practice.

Published in:: Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 3, p. 129
Publication type:: Article

Oncologists' Common Misconceptions About Biosimilars Revealed in a Recent Survey.

Published in:: Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 3, p. 128
Publication type:: Article

Comparing Single-Center Outcomes Between Reference and Biosimilar Granulocyte Colony-Stimulating Factor Drugs Used for Autologous Stem-Cell Mobilization.

Published in:

Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 3, p. 119

By:

Bartels, Trace;
Klanderman, Molly;
Rogers, Jaime;
Gray, Kristin;
Kosiorek, Heidi;
Coughlin, Chris

Publication type:

Article

Adoption of Biosimilars--Why the Delay?

Published in:

Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 3, p. 117

By:

Soefje, Scott A.

Publication type:

Article